DOI: 10.1016/0143-4179(88)90039-x. Levels of MET-enkephalin, LEU-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatment

Levels of MET-enkephalin, LEU-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatment

10.1016/0143-4179(88)90039-x

Crossref journal-article

Elsevier BV

Neuropeptides (78)

Bibliography

Taquet, H., Nomoto, M., Rose, S., Jenner, P., Javoy-Agid, F., Mauborgne, A., Benoliel, J. J., Marsden, C. D., Legrand, J. C., Agid, Y., Hamon, M., & Cesselin, F. (1988). Levels of MET-enkephalin, LEU-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatment. Neuropeptides, 12(3), 105â110.

Authors 12

H. Taquet (first)
M. Nomoto (additional)
S. Rose (additional)
P. Jenner (additional)
F. Javoy-Agid (additional)
A. Mauborgne (additional)
J.J. Benoliel (additional)
C.D. Marsden (additional)
J.C. Legrand (additional)
Y. Agid (additional)
M. Hamon (additional)
F. Cesselin (additional)

References 18 Referenced 34

10.1016/S0079-6123(08)64600-2 / Prog. Brain Res. / Neuropeptides and Parkinson's disease by Agid (1986)
10.1093/brain/109.1.143 / Brain / Neuropeptides and dopamine in the marmoset. Effect of treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): an animal model for Parkinson's disease? by Allen (1986)
{'key': '10.1016/0143-4179(88)90039-X_BIB3', 'first-page': '4546', 'article-title': 'A primate model of Parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine', 'volume': '80', 'author': 'Burns', 'year': '1983'} / A primate model of Parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by Burns (1983)
{'key': '10.1016/0143-4179(88)90039-X_BIB4', 'series-title': "Parkinson's disease: current progress, problems and management", 'first-page': '109', 'article-title': "Biochemical abnormalities in some extrastriatal neuronal systems in Parkinson's disease", 'author': 'Hornykiewicz', 'year': '1980'} / Parkinson's disease: current progress, problems and management / Biochemical abnormalities in some extrastriatal neuronal systems in Parkinson's disease by Hornykiewicz (1980)
10.1016/0304-3940(84)90467-1 / Neurosci. Lett. / 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset by Jenner (1984)
10.1111/j.1471-4159.1986.tb00793.x / J. Neurochem. / Lack of change in basal ganglia neuropeptide content following subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of the common marmoset by Jenner (1986)
10.1002/ana.410180504 / Ann. Neurol. / Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers by Kish (1985)
10.1016/0163-7258(87)90062-3 / Pharmac. Ther. / Neurotoxins, parkinsonism and Parkinson's disease by Langston (1987)
10.1016/0006-8993(83)90403-1 / Brain Res. / Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains by Mauborgne (1983)
10.1016/0024-3205(85)90292-9 / Life Sci. / The endogenous opioid system in neurological disorders of the basal ganglia by Sandyk (1985)
10.1212/WNL.36.2.250 / Neurology / MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's disease by Snyder (1986)
10.1016/0006-8993(82)91135-0 / Brain Res. / CCK-8 immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients by Studler (1982)
10.1016/0006-8993(85)91081-9 / Brain Res. / Dynorphin levels in parkinsonian patients: Leu5-enkephalin production from either proenkephalin A or prodynorphin in human brain by Taquet (1985)
10.1016/0006-8993(83)90071-9 / Brain Res. / Parkinson's disease affects differently Met5- and Leu5-enkephalin in the human brain by Taquet (1983)
10.1016/0006-8993(87)90697-4 / Brain Res. / Brain neuropeptides in progressive supranuclear palsy by Taquet (1987)
10.1016/0006-8993(84)90217-8 / Brain Res. / Substance P immunoreactivity in the post-mortem parkinsonian brain by Tenovou (1984)
10.1111/j.1471-4159.1982.tb07897.x / J. Neurochem. by Wagner (1982)
10.1016/0006-8993(84)90133-1 / Brain Res. / Primate model of Parkinson's disease: alterations in multiple opioid systems in the basal ganglia by Zamir (1984)

Dates

Type	When
Created	21 years, 4 months ago (April 18, 2004, 11:26 p.m.)
Deposited	6 years, 6 months ago (Feb. 11, 2019, 2:55 p.m.)
Indexed	2 months, 1 week ago (June 25, 2025, 1:24 a.m.)
Issued	36 years, 11 months ago (Oct. 1, 1988)
Published	36 years, 11 months ago (Oct. 1, 1988)
Published Print	36 years, 11 months ago (Oct. 1, 1988)

Funders 0

None

BibTeX

@article{Taquet_1988, title={Levels of MET-enkephalin, LEU-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatment}, volume={12}, ISSN={0143-4179}, url={http://dx.doi.org/10.1016/0143-4179(88)90039-x}, DOI={10.1016/0143-4179(88)90039-x}, number={3}, journal={Neuropeptides}, publisher={Elsevier BV}, author={Taquet, H. and Nomoto, M. and Rose, S. and Jenner, P. and Javoy-Agid, F. and Mauborgne, A. and Benoliel, J.J. and Marsden, C.D. and Legrand, J.C. and Agid, Y. and Hamon, M. and Cesselin, F.}, year={1988}, month=oct, pages={105–110} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        6,
        25
      ]
    ],
    "date-time": "2025-06-25T05:24:55Z",
    "timestamp": 1750829095645
  },
  "reference-count": 18,
  "publisher": "Elsevier BV",
  "issue": "3",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            1988,
            10,
            1
          ]
        ],
        "date-time": "1988-10-01T00:00:00Z",
        "timestamp": 591667200000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        1988,
        10
      ]
    ]
  },
  "DOI": "10.1016/0143-4179(88)90039-x",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2004,
        4,
        19
      ]
    ],
    "date-time": "2004-04-19T03:26:56Z",
    "timestamp": 1082345216000
  },
  "page": "105-110",
  "source": "Crossref",
  "is-referenced-by-count": 34,
  "title": "Levels of MET-enkephalin, LEU-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatment",
  "prefix": "10.1016",
  "volume": "12",
  "author": [
    {
      "given": "H.",
      "family": "Taquet",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "M.",
      "family": "Nomoto",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "S.",
      "family": "Rose",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "P.",
      "family": "Jenner",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "F.",
      "family": "Javoy-Agid",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "A.",
      "family": "Mauborgne",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "J.J.",
      "family": "Benoliel",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "C.D.",
      "family": "Marsden",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "J.C.",
      "family": "Legrand",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Y.",
      "family": "Agid",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "M.",
      "family": "Hamon",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "F.",
      "family": "Cesselin",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1016/0143-4179(88)90039-X_BIB1",
      "doi-asserted-by": "crossref",
      "first-page": "107",
      "DOI": "10.1016/S0079-6123(08)64600-2",
      "article-title": "Neuropeptides and Parkinson's disease",
      "volume": "66",
      "author": "Agid",
      "year": "1986",
      "journal-title": "Prog. Brain Res."
    },
    {
      "key": "10.1016/0143-4179(88)90039-X_BIB2",
      "doi-asserted-by": "crossref",
      "first-page": "143",
      "DOI": "10.1093/brain/109.1.143",
      "article-title": "Neuropeptides and dopamine in the marmoset. Effect of treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): an animal model for Parkinson's disease?",
      "volume": "109",
      "author": "Allen",
      "year": "1986",
      "journal-title": "Brain"
    },
    {
      "key": "10.1016/0143-4179(88)90039-X_BIB3",
      "first-page": "4546",
      "article-title": "A primate model of Parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",
      "volume": "80",
      "author": "Burns",
      "year": "1983"
    },
    {
      "key": "10.1016/0143-4179(88)90039-X_BIB4",
      "series-title": "Parkinson's disease: current progress, problems and management",
      "first-page": "109",
      "article-title": "Biochemical abnormalities in some extrastriatal neuronal systems in Parkinson's disease",
      "author": "Hornykiewicz",
      "year": "1980"
    },
    {
      "key": "10.1016/0143-4179(88)90039-X_BIB5",
      "doi-asserted-by": "crossref",
      "first-page": "85",
      "DOI": "10.1016/0304-3940(84)90467-1",
      "article-title": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset",
      "volume": "50",
      "author": "Jenner",
      "year": "1984",
      "journal-title": "Neurosci. Lett."
    },
    {
      "key": "10.1016/0143-4179(88)90039-X_BIB6",
      "doi-asserted-by": "crossref",
      "first-page": "1548",
      "DOI": "10.1111/j.1471-4159.1986.tb00793.x",
      "article-title": "Lack of change in basal ganglia neuropeptide content following subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of the common marmoset",
      "volume": "47",
      "author": "Jenner",
      "year": "1986",
      "journal-title": "J. Neurochem."
    },
    {
      "key": "10.1016/0143-4179(88)90039-X_BIB7",
      "doi-asserted-by": "crossref",
      "first-page": "530",
      "DOI": "10.1002/ana.410180504",
      "article-title": "Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers",
      "volume": "18",
      "author": "Kish",
      "year": "1985",
      "journal-title": "Ann. Neurol."
    },
    {
      "key": "10.1016/0143-4179(88)90039-X_BIB8",
      "doi-asserted-by": "crossref",
      "first-page": "19",
      "DOI": "10.1016/0163-7258(87)90062-3",
      "article-title": "Neurotoxins, parkinsonism and Parkinson's disease",
      "volume": "32",
      "author": "Langston",
      "year": "1987",
      "journal-title": "Pharmac. Ther."
    },
    {
      "key": "10.1016/0143-4179(88)90039-X_BIB9",
      "doi-asserted-by": "crossref",
      "first-page": "167",
      "DOI": "10.1016/0006-8993(83)90403-1",
      "article-title": "Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains",
      "volume": "268",
      "author": "Mauborgne",
      "year": "1983",
      "journal-title": "Brain Res."
    },
    {
      "key": "10.1016/0143-4179(88)90039-X_BIB10",
      "doi-asserted-by": "crossref",
      "first-page": "1655",
      "DOI": "10.1016/0024-3205(85)90292-9",
      "article-title": "The endogenous opioid system in neurological disorders of the basal ganglia",
      "volume": "37",
      "author": "Sandyk",
      "year": "1985",
      "journal-title": "Life Sci."
    },
    {
      "key": "10.1016/0143-4179(88)90039-X_BIB11",
      "doi-asserted-by": "crossref",
      "first-page": "250",
      "DOI": "10.1212/WNL.36.2.250",
      "article-title": "MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's disease",
      "volume": "36",
      "author": "Snyder",
      "year": "1986",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/0143-4179(88)90039-X_BIB12",
      "doi-asserted-by": "crossref",
      "first-page": "176",
      "DOI": "10.1016/0006-8993(82)91135-0",
      "article-title": "CCK-8 immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients",
      "volume": "243",
      "author": "Studler",
      "year": "1982",
      "journal-title": "Brain Res."
    },
    {
      "key": "10.1016/0143-4179(88)90039-X_BIB13",
      "doi-asserted-by": "crossref",
      "first-page": "390",
      "DOI": "10.1016/0006-8993(85)91081-9",
      "article-title": "Dynorphin levels in parkinsonian patients: Leu5-enkephalin production from either proenkephalin A or prodynorphin in human brain",
      "volume": "341",
      "author": "Taquet",
      "year": "1985",
      "journal-title": "Brain Res."
    },
    {
      "key": "10.1016/0143-4179(88)90039-X_BIB14",
      "doi-asserted-by": "crossref",
      "first-page": "379",
      "DOI": "10.1016/0006-8993(83)90071-9",
      "article-title": "Parkinson's disease affects differently Met5- and Leu5-enkephalin in the human brain",
      "volume": "280",
      "author": "Taquet",
      "year": "1983",
      "journal-title": "Brain Res."
    },
    {
      "key": "10.1016/0143-4179(88)90039-X_BIB15",
      "doi-asserted-by": "crossref",
      "first-page": "178",
      "DOI": "10.1016/0006-8993(87)90697-4",
      "article-title": "Brain neuropeptides in progressive supranuclear palsy",
      "volume": "411",
      "author": "Taquet",
      "year": "1987",
      "journal-title": "Brain Res."
    },
    {
      "key": "10.1016/0143-4179(88)90039-X_BIB16",
      "doi-asserted-by": "crossref",
      "first-page": "113",
      "DOI": "10.1016/0006-8993(84)90217-8",
      "article-title": "Substance P immunoreactivity in the post-mortem parkinsonian brain",
      "volume": "303",
      "author": "Tenovou",
      "year": "1984",
      "journal-title": "Brain Res."
    },
    {
      "key": "10.1016/0143-4179(88)90039-X_BIB17",
      "doi-asserted-by": "crossref",
      "first-page": "1241",
      "DOI": "10.1111/j.1471-4159.1982.tb07897.x",
      "volume": "38",
      "author": "Wagner",
      "year": "1982",
      "journal-title": "J. Neurochem."
    },
    {
      "key": "10.1016/0143-4179(88)90039-X_BIB18",
      "doi-asserted-by": "crossref",
      "first-page": "356",
      "DOI": "10.1016/0006-8993(84)90133-1",
      "article-title": "Primate model of Parkinson's disease: alterations in multiple opioid systems in the basal ganglia",
      "volume": "322",
      "author": "Zamir",
      "year": "1984",
      "journal-title": "Brain Res."
    }
  ],
  "container-title": "Neuropeptides",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:014341798890039X?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:014341798890039X?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2019,
        2,
        11
      ]
    ],
    "date-time": "2019-02-11T19:55:27Z",
    "timestamp": 1549914927000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/014341798890039X"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        1988,
        10
      ]
    ]
  },
  "references-count": 18,
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          1988,
          10
        ]
      ]
    }
  },
  "alternative-id": [
    "014341798890039X"
  ],
  "URL": "http://dx.doi.org/10.1016/0143-4179(88)90039-X",
  "relation": {},
  "ISSN": [
    "0143-4179"
  ],
  "subject": [],
  "container-title-short": "Neuropeptides",
  "published": {
    "date-parts": [
      [
        1988,
        10
      ]
    ]
  }
}